United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - pyridostigmine bromide - oral tablet - 60mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - pyridostigmine bromide - oral tablet - 60mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - pyridostigmine bromide - oral tablet - 60mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - pyridostigmine bromide - oral tablet - 60mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - pyridostigmine bromide - oral tablet - 60mg

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - pyridostigmine bromide, quantity: 60 mg - tablet, sugar coated - excipient ingredients: iron oxide yellow; colloidal anhydrous silica; acacia; magnesium stearate; maize starch; povidone; liquid paraffin; purified talc; rice starch; hard paraffin; iron oxide red; sucrose; pregelatinised potato starch - indications as at 3 august 1992: mestinon is useful in the treatment of myasthenia gravis.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - pyridostigmine bromide, quantity: 180 mg - tablet, modified release - excipient ingredients: zein; carnauba wax; colloidal anhydrous silica; magnesium stearate; calcium phosphate - indications as at 3 august 1992: mestinon is useful in the treatment of myasthenia gravis.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - pyridostigmine bromide, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; purified talc; lactose monohydrate; colloidal anhydrous silica; pregelatinised potato starch - indications as at 3 august 1992: mestinon is useful in the treatment of myasthenia gravis.

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide tablets are useful in the treatment of myasthenia gravis. pyridostigmine bromide tablets are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

Israel - English - Ministry of Health

megapharm ltd - pyridostigmine bromide - dragee - pyridostigmine bromide 60.0 mg - pyridostigmine - pyridostigmine - treatment of myasthenia gravis.